Keyphrases
Hypoglycemia
100%
Neurodevelopmental Outcome
100%
Glycemia
100%
Executive Function
50%
Blood Glucose
50%
Motor Function
50%
Risk Ratio
50%
Glucose Concentration
50%
Visual-motor
50%
Risk Difference
50%
Neurosensory Impairment
50%
Interstitial Glucose
50%
Neonatal Hypoglycemia
50%
Neurodevelopment
33%
Intervention Threshold
33%
New Zealand
16%
High Risk
16%
Threshold Method
16%
Late Development
16%
Dose Effect
16%
Whole Blood
16%
Risk Factors
16%
Poor Performance
16%
Neonate
16%
Cognitive Function
16%
Visual Function
16%
Non-associated
16%
School Age
16%
Randomized Trial
16%
Acute Disease
16%
Glycemic Status
16%
Term Infants
16%
Hypoglycemia Risk
16%
Optimal Intervention
16%
Neurological Impairment
16%
Late Preterm Infant
16%
Late Preterm
16%
Hypoglycemic Episodes
16%
Moderate Preterm
16%
Fetal-to-neonatal Transition
16%
Perinatal Center
16%
Diabetic Mother
16%
Medicine and Dentistry
Hypoglycemia
100%
Blood Glucose
42%
Motor Performance
42%
Executive Function
42%
Attributable Risk
42%
Neonatal Hypoglycemia
42%
Nerve Cell Differentiation
28%
Neonate
14%
Clinician
14%
Acute Disease
14%
Antidiabetic Agent
14%
Glycemic
14%
Maternal Diabetes Mellitus
14%
Neuroscience
Hypoglycemia
100%
Executive Function
30%
Nerve Cell Differentiation
20%
Diabetes Mellitus
10%
Cognitive Function
10%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoglycemia
100%
Maternal Diabetes Mellitus
10%
Antidiabetic Agent
10%
Acute Disease
10%